Clinical Trial Update: Effect of SCH 497079 on Metabolic Parameters and Influence of Race/Ethnic Origin on Therapeutic Response (Study P05338)(COMPLETED) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating SCH 497079 on metabolic parameters with consideration of race/ethnic origin in adults with Type 2 Diabetes Mellitus; study completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SCH 497079

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2017-02-15